Table 3.
Characteristics of surgery, adjuvant therapy and evolution of patients.
| Variable | n | % |
|---|---|---|
| Type of mastectomy | ||
| Skin-sparing type I–II | 31 | 45.6% |
| Skin-sparing type IV | 8 | 11.7% |
| Nipple skin-sparing | 10 | 14.7% |
| Radical mastectomy | 19 | 28.0% |
| Breast reconstruction timing | ||
| Immediate | 64 | 94.1% |
| Delayed | 4 | 5.9% |
| Type of reconstruction | ||
| Expander-prosthesis | 21 | 30.9% |
| Becker expander | 17 | 25% |
| Latissimus dorsi muscle flap | 17 | 25% |
| Matrix acellular | 6 | 8.8% |
| Direct prosthesis | 7 | 10.3% |
| Lymph node management | ||
| None | 2 | 2.9% |
| Sentinel lymph node biopsy | 39 | 57.4% |
| Axillary lymph node dissection | 27 | 39.7% |
| Adjuvant Radiotherapy | ||
| Yes | 27 | 39.7% |
| No | 41 | 60.3% |
| Chemotherapy | ||
| No | 24 | 35.5% |
| Neo-adjuvant | 18 | 26.5% |
| Adjuvant | 26 | 38.2% |
| Breast symmetrisation | ||
| Yes | 39 | 57.4% |
| No | 29 | 42.6% |
| Evolution after first surgery | ||
| Successful | 33 | 48.5% |
| Reoperation | 35 | 51.5% |